ATE139565T1 - Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid - Google Patents

Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid

Info

Publication number
ATE139565T1
ATE139565T1 AT91900632T AT91900632T ATE139565T1 AT E139565 T1 ATE139565 T1 AT E139565T1 AT 91900632 T AT91900632 T AT 91900632T AT 91900632 T AT91900632 T AT 91900632T AT E139565 T1 ATE139565 T1 AT E139565T1
Authority
AT
Austria
Prior art keywords
solubilization
purification
releasing peptide
peptide receptor
gastrin releasing
Prior art date
Application number
AT91900632T
Other languages
English (en)
Inventor
Richard I Feldman
James M Wu
Elaina Mann
Anne Larocca
James C Jenson
Original Assignee
Berlex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/426,150 external-priority patent/US5215963A/en
Application filed by Berlex Lab filed Critical Berlex Lab
Application granted granted Critical
Publication of ATE139565T1 publication Critical patent/ATE139565T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/286—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5758—Gastrin releasing peptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT91900632T 1989-10-24 1990-10-23 Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid ATE139565T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/426,150 US5215963A (en) 1989-10-24 1989-10-24 Solubilization and purification of the active gastrin releasing peptide receptor
US53365990A 1990-06-05 1990-06-05

Publications (1)

Publication Number Publication Date
ATE139565T1 true ATE139565T1 (de) 1996-07-15

Family

ID=27026933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91900632T ATE139565T1 (de) 1989-10-24 1990-10-23 Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid

Country Status (8)

Country Link
EP (2) EP0524173B1 (de)
JP (2) JPH05506981A (de)
AT (1) ATE139565T1 (de)
AU (2) AU641210B2 (de)
CA (2) CA2069965A1 (de)
DE (1) DE69027542T2 (de)
ES (1) ES2089182T3 (de)
WO (2) WO1991006646A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641210B2 (en) * 1989-10-24 1993-09-16 Berlex Laboratories, Inc. Gastrin releasing peptide receptor
AU1793092A (en) * 1991-03-15 1992-10-21 Berlex Laboratories, Inc. Receptors for bombesin-like peptides
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
US20050019325A1 (en) 1996-01-08 2005-01-27 Carter Paul J. WSX receptor agonist antibodies
WO1998047524A1 (en) * 1997-04-22 1998-10-29 Curators Of The University Of Missouri Gastrin receptor-avid peptide conjugates
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US20050287519A1 (en) * 2004-05-12 2005-12-29 Merchiers Pascal G Methods, compositions and compound assays for inhibiting amyloid-beta protein production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641210B2 (en) * 1989-10-24 1993-09-16 Berlex Laboratories, Inc. Gastrin releasing peptide receptor
AU1707892A (en) * 1991-05-22 1993-03-11 Ludwig Institute For Cancer Research Gastrin-binding protein

Also Published As

Publication number Publication date
ES2089182T3 (es) 1996-10-01
AU640480B2 (en) 1993-08-26
AU7740691A (en) 1991-05-31
WO1991006646A1 (en) 1991-05-16
DE69027542D1 (de) 1996-07-25
WO1991006647A1 (en) 1991-05-16
EP0524173B1 (de) 1996-06-19
AU641210B2 (en) 1993-09-16
EP0524173A1 (de) 1993-01-27
EP0497866A1 (de) 1992-08-12
AU7039491A (en) 1991-05-31
DE69027542T2 (de) 1996-12-12
CA2067766A1 (en) 1991-04-25
CA2069965A1 (en) 1991-04-25
JPH05505097A (ja) 1993-08-05
JPH05506981A (ja) 1993-10-14

Similar Documents

Publication Publication Date Title
ATE162532T1 (de) Merschliches cnp-gen und vorläufer protein
DE69730038D1 (de) Lösliche monovalente und multivalente mhc klasse ii fusionsproteine und deren verwendungen
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
ES2176284T3 (es) Amidas de peptidos inhibidoras del cancer de seres humanos.
KR880009035A (ko) Apc 폴리펩티드의 전구 단백질, 이를 위한 dna 암호화, 및 이 dna와 단백질의 진단 용도
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
ATE128715T1 (de) Polypeptide induzierende faktoren in knochen und knorpel.
SE8803847A0 (sv) Neuromodulerande peptid
DE3382117D1 (de) Molekulare klonierung und charakterisierung der das menschliche relaxin kodierenden gen-sequenz.
TR199501630A2 (tr) Peptid p277 benzerleri ve diagnoz ve dibetlerin'lerin tedavisi icin onlari iceren kompozisyonlar.
DK499886A (da) Peptid
DE3586979D1 (de) Neue zns-aktive peptide mit wirkung auf das cholinerge system.
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ES2089182T3 (es) Solubilizacion y purificacion del receptor del peptido liberador de gastrina.
ES2057572T3 (es) Agentes de reconocimiento.
ATE115409T1 (de) Glykoprotein-hormonrezeptor-moleküle.
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
DK262986D0 (da) Peptidmateriale med thymushumoral aktivitet
EP0723016A3 (de) Leukocyten-aktivierender Faktor
DK1612555T3 (da) Kryptiske peptider til anvendelse til at inducere immunologisk tolerance
NO177858C (no) Peptid
DE3869939D1 (de) Biologisch wirksame peptide.
DE3689850D1 (de) Peptide und deren Verwendung in der Therapie.
DE3888078D1 (de) Veränderungsverfahren für Peptide und Proteine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee